{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T12:47:35Z","timestamp":1649162855541},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10067-021-05616-8","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T01:01:49Z","timestamp":1612918909000},"page":"2699-2705","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["First trimester combined screening test for aneuploidies in anti-Ro carriers pregnant women"],"prefix":"10.1007","volume":"40","author":[{"given":"N.","family":"Mart\u00ednez-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Robles Marhuenda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"De la Calle Fern\u00e1ndez-Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. L.","family":"Bartha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,9]]},"reference":[{"key":"5616_CR1","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/art.34380","volume":"64","author":"M Satoh","year":"2012","unstructured":"Satoh M, Chan EK, Ho LA et al (2012) Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum 64:2319\u20132327","journal-title":"Arthritis Rheum"},{"key":"5616_CR2","volume-title":"Autoanticuerpos. Gu\u00eda r\u00e1pida","author":"AM Bielsa Masdeu","year":"2010","unstructured":"Bielsa Masdeu AM (2010) Autoanticuerpos. Gu\u00eda r\u00e1pida, 2nd edn. Ana Mar\u00eda Bielsa Masdeu, Madrid","edition":"2"},{"key":"5616_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.curtheres.2014.06.004","volume":"76","author":"YP Guo","year":"2014","unstructured":"Guo YP, Wang CG, Liu X, Huang YQ, Guo DL, Jing XZ, Yuan CG, Yang S, Liu JM, Han MS, Li HX (2014) The prevalence of antinuclear antibodies in the general population of china: a cross-sectional study. Curr Ther Res Clin Exp 76:116\u2013119","journal-title":"Curr Ther Res Clin Exp"},{"key":"5616_CR4","doi-asserted-by":"publisher","first-page":"592","DOI":"10.7326\/0003-4819-99-5-592","volume":"99","author":"LA Lee","year":"1983","unstructured":"Lee LA, Bias WB, Arnett FC Jr et al (1983) Immunogenetics of the neonatal lupus syndrome. Ann Intern Med 99:592\u2013596","journal-title":"Ann Intern Med"},{"key":"5616_CR5","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/00005792-198411000-00003","volume":"63","author":"RM Watson","year":"1984","unstructured":"Watson RM, Lane AT, Barnett NK, Bias WB, Arnett FC, Provost TT (1984) Neonatal lupus erythematosus A clinical, serological and immunogenetic study with review of the literature. Medicine 63:362\u2013378","journal-title":"Medicine"},{"issue":"4","key":"5616_CR6","first-page":"95","volume":"126","author":"P Brito-Zer\u00f3n","year":"2020","unstructured":"Brito-Zer\u00f3n P, Pasoto SG, Robles-Marhuenda A, Mandl T, Vissink A, Armagan B, Praprotnik S, Nocturne G, Sebastian A, Fernandes Mo\u00e7a Trevisani V, Retamozo S, Acar-Denizli N, Wiland P, Sis\u00f3-Almirall A, Bootsma H, Mariette X, Ramos-Casals M, Kostov B, Sj\u00f6gren Big Data Consortium (2020) Autoimmune congenital heart block and primary Sj\u00f6gren\u2019s syndrome: characterisation and outcomes of 49 cases. Clin Exp Rheumatol 126(4):95\u2013102","journal-title":"Clin Exp Rheumatol"},{"key":"5616_CR7","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S0140-6736(83)90647-5","volume":"2","author":"RG Hull","year":"1983","unstructured":"Hull RG, Harris EN, Morgan SH, Hughes GR (1983) Anti-Ro antibodies and abortions in women with SLE. Lancet 2:1138","journal-title":"Lancet"},{"key":"5616_CR8","first-page":"90","volume":"13","author":"RM Watson","year":"1986","unstructured":"Watson RM, Braunstein BL, Watson AJ, Hochberg MC, Provost TT (1986) Fetal wastage in women with anti-Ro(SSA) antibody. J Rheumatol 13:90\u201394","journal-title":"J Rheumatol"},{"key":"5616_CR9","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/rheumatology\/37.7.740","volume":"37","author":"CP Mavragani","year":"1998","unstructured":"Mavragani CP, Dafni UG, Txioufas AG, Moutsopoulos HM (1998) Pregnancy outcome and anti-Ro\/SS-A in autoimmune disease: a retrospective cohort study. Br J Rheumatol 37:740\u2013745","journal-title":"Br J Rheumatol"},{"key":"5616_CR10","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/oxfordjournals.qjmed.a068889","volume":"87","author":"HD Le Thi","year":"1994","unstructured":"Le Thi HD, Wechsler B, Piette JC, Bletry O, Godeau P (1994) Pregnancy and its outcome in systemic lupus erythematosus. Q J Med 87:721\u2013729","journal-title":"Q J Med"},{"key":"5616_CR11","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1191\/0961203302lu252oa","volume":"11","author":"A Brucato","year":"2002","unstructured":"Brucato A, Doria A, Frassi M, Castellino G, Franceschini F, Faden D, Pisoni MP, Solerte L, Muscar\u00e0 M, Lojacono A, Motta M, Cavazzana I, Ghirardello A, Vescovi F, Tombini V, Cimaz R, Gambari PF, Meroni PL, Canesi B, Tincani A (2002) Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro\/SSA antibodies: a prospective controlled study. Lupus 11:716\u2013721","journal-title":"Lupus"},{"key":"5616_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/aogs.12785","volume":"95","author":"A Skog","year":"2016","unstructured":"Skog A, Lagnefeldt L, Conner P, Wahren-Herlenius M, Sonesson SE (2016) Outcome in 212 anti-Ro\/SS-A positive pregnancies and population-based incidence of congenital heart block. Acta Obstet Gynecol Scand 95:98\u2013105","journal-title":"Acta Obstet Gynecol Scand"},{"key":"5616_CR13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s12026-016-8888-5","volume":"65","author":"N Mart\u00ednez-S\u00e1nchez","year":"2017","unstructured":"Mart\u00ednez-S\u00e1nchez N, P\u00e9rez-Pinto S, Robles-Marhuenda \u00c1, Arnalich-Fern\u00e1ndez F, Mart\u00edn Came\u00e1n M, Hueso Zalvide E, Bartha JL (2017) Obstetric and perinatal outcome in anti-Ro\/SSA-positive pregnant women: a prospective cohort study. Immunol Res 65:487\u2013494. https:\/\/doi.org\/10.1007\/s12026-016-8888-5","journal-title":"Immunol Res"},{"key":"5616_CR14","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1136\/annrheumdis-2016-210927","volume":"76","author":"AR Lisney","year":"2017","unstructured":"Lisney AR, Szelinski F, Reiter K, Burmester GR, Rose T, Dorner T (2017) High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block. Ann Rheum Dis 76:1476\u20131480","journal-title":"Ann Rheum Dis"},{"issue":"202","key":"5616_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4049\/jimmunol.1800357","volume":"1","author":"RM Clancy","year":"2019","unstructured":"Clancy RM, Halushka M, Rasmussen SE, Lhakhang T, Chang M, Buyon JP (2019) Siglec-1 macrophages and the contribution of IFN to the development of autoimmune congenital heart block. J Immunol 1(202):48\u201355","journal-title":"J Immunol"},{"issue":"1","key":"5616_CR16","doi-asserted-by":"publisher","first-page":"e12995","DOI":"10.1111\/sji.12995","volume":"93","author":"A Ambrosi","year":"2021","unstructured":"Ambrosi A, Thorlacius GE, Sonesson SE, Wahren-Herlenius M (2021) Interferons and innate immune activation in autoimmune congenital heart block. Scand J Immunol 93(1):e12995. https:\/\/doi.org\/10.1111\/sji.12995","journal-title":"Scand J Immunol"},{"key":"5616_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/pd.2637","volume":"31","author":"KH Nicolaides","year":"2011","unstructured":"Nicolaides KH (2011) Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 31:7\u201315","journal-title":"Prenat Diagn"},{"key":"5616_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/uog.1860","volume":"25","author":"KH Nicolaides","year":"2005","unstructured":"Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O (2005) Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 25:221\u2013226","journal-title":"Ultrasound Obstet Gynecol"},{"key":"5616_CR19","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/0002-9378(84)90530-1","volume":"148","author":"IR Merkatz","year":"1984","unstructured":"Merkatz IR, Nitowsky HM, Macri JN, Johnson WE (1984) An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 148:886\u2013894","journal-title":"Am J Obstet Gynecol"},{"key":"5616_CR20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1471-0528.1988.tb06601.x","volume":"95","author":"J Canick","year":"1988","unstructured":"Canick J, Knight GJ, Palomaki GE et al (1988) Low second trimester maternal serum unconjugated oestriol in pregnancies with Down\u2019s syndrome. BJOG 95:330\u2013333","journal-title":"BJOG"},{"key":"5616_CR21","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/0002-9378(90)90700-H","volume":"163","author":"JN Macri","year":"1990","unstructured":"Macri JN, Kasturi RV, Krantz DA, Cook EJ, Moore ND, Young JA, Romero K, Larsen JW Jr (1990) Maternal serum Down syndrome screening: free beta protein is a more effective marker than human chorionic gonadotrophin. Am J Obstet Gynecol 163:1248\u20131253","journal-title":"Am J Obstet Gynecol"},{"key":"5616_CR22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/pd.1970121005","volume":"12","author":"JM Van Lith","year":"1993","unstructured":"Van Lith JM, Pratt JJ, Beekhuis JR, Mantingh A (1993) Second trimester maternal serum immuno-reactive inhibin as a marker for fetal Down\u2019s syndrome. Prenat Diagn 12:801\u2013806","journal-title":"Prenat Diagn"},{"key":"5616_CR23","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1471-0528.1993.tb12973.x","volume":"100","author":"B Brambati","year":"1993","unstructured":"Brambati B, Macintosh MCM, Teisner B, Maguiness S, Shrimanker K, Lanzani A, Bonacchi I, Tului L, Chard T, Grudzinskas JG (1993) Low maternal serum level of pregnancy associated plasma protein (PAPP-A) in the first trimester in association with abnormal fetal karyotype. BJOG 100:324\u2013326","journal-title":"BJOG"},{"key":"5616_CR24","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1056\/NEJM199605093341904","volume":"334","author":"DA Aitken","year":"1996","unstructured":"Aitken DA, Wallace EM, Crossley JA, Swanston IA, van Pareren Y, van Maarle M, Groome NP, Macri JN, Connor JM (1996) Dimeric inhibin A as a marker for Down\u2019s syndrome in early pregnancy. N Engl J Med 334:1231\u20131236","journal-title":"N Engl J Med"},{"key":"5616_CR25","first-page":"11","volume":"33","author":"K Spenser","year":"2013","unstructured":"Spenser K, Cowans NJ (2013) Correction of first trimester biochemical aneuploidy screening markers for smoking status: influence of gestational age, maternal ethnicity and cigarette dosage. Prenat Diagn 33:11\u2013123","journal-title":"Prenat Diagn"},{"key":"5616_CR26","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/uog.5332","volume":"31","author":"KO Kagan","year":"2008","unstructured":"Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH (2008) First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 31:493\u2013502","journal-title":"Ultrasound Obstet Gynecol"},{"key":"5616_CR27","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/pd.2589","volume":"30","author":"K Spencer","year":"2010","unstructured":"Spencer K, Cowans NJ, Spencer CE, Achillea N (2010) A re-evaluation of the influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy. Prenat Diagn 30:937\u2013940","journal-title":"Prenat Diagn"},{"key":"5616_CR28","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1471-0528.2011.02904.x","volume":"118","author":"S Kuc","year":"2011","unstructured":"Kuc S, Wortelboer E, Koster M, De Valk H, Schielen P, Visser G (2011) Prediction of macrosomia at birth in type-1 and 2 diabetic pregnancies with biomarkers of early placentation. BJOG 118:748\u2013754","journal-title":"BJOG"},{"issue":"4","key":"5616_CR29","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1471-0528.2011.03253.x","volume":"119","author":"MD Savvidou","year":"2012","unstructured":"Savvidou MD, Syngelaki A, Muhaisen M, Emelyanenko E, Nicolaides KH (2012) First trimester maternal serum free \u03b2-human chorionic gonadotropin and pregnancy-associated plasma protein A in pregnancies complicated by diabetes mellitus. BJOG 119(4):410\u2013416","journal-title":"BJOG"},{"key":"5616_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1600-0412.2011.01212.x","volume":"91","author":"HN Madsen","year":"2012","unstructured":"Madsen HN, Ekelund CK, T\u00f8rring N, Ovesen PG, Friis-Hansen L, Ringholm L et al (2012) Impact of type 1 diabetes and glycemic control on fetal aneuploidy biochemical markers. Acta Obstet Gynecol Scand 91:57\u201361","journal-title":"Acta Obstet Gynecol Scand"},{"key":"5616_CR31","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","volume":"350","author":"YM Lo","year":"1997","unstructured":"Lo YM et al (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350:485\u2013487","journal-title":"Lancet"},{"key":"5616_CR32","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nm.2312","volume":"17","author":"EA Papageorgiou","year":"2011","unstructured":"Papageorgiou EA, Karagrigoriou A, Tsaliki E, Velissariou V, Carter NP, Patsalis PC (2011) Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat Med 17:510\u2013513","journal-title":"Nat Med"},{"key":"5616_CR33","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/uog.17484","volume":"50","author":"M Gil","year":"2017","unstructured":"Gil M et al (2017) Analysis of cell-free DNA in maternal blood screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 50:302\u2013314","journal-title":"Ultrasound Obstet Gynecol"},{"key":"5616_CR34","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/pd.1970151108","volume":"15","author":"F Clark","year":"1995","unstructured":"Clark F, Dickinson JE, Walters BN, Marshall LR, O\u2019Leary PC (1995) Elevated mid-trimester hCG and maternal lupus anticoagulant. Prenat Diagn 15:1035\u20131039","journal-title":"Prenat Diagn"},{"key":"5616_CR35","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/1097-0223(200010)20:10<851::AID-PD932>3.0.CO;2-L","volume":"20","author":"EL Ferriman","year":"2000","unstructured":"Ferriman EL, Sehmi IK, Jones R, Railton A, Hilton RC, Cuckle HS (2000) False-positive maternal serum screening in systemic lupus erythematosis: a case report. Prenat Diagn 20:851","journal-title":"Prenat Diagn"},{"key":"5616_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1097-0223(200001)20:1<12::AID-PD743>3.0.CO;2-5","volume":"20","author":"R Maymon","year":"2000","unstructured":"Maymon R, Sehmi IK, Herman A, Jones RC, Sherman D, Cuckle H (2000) Serum inhibin A levels in pregnant women with systemic lupus erythematosus or antiphospholipid syndrome. Prenat Diagn 20:12\u201316","journal-title":"Prenat Diagn"},{"issue":"5","key":"5616_CR37","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s10067-019-04525-1","volume":"38","author":"MJ Rego de Sousa","year":"2019","unstructured":"Rego de Sousa MJ et al (2019) First trimester combined screening in patients with systemic lupus erythematosus: impact of pre-analytical variables on risk assessment. Clin Rheumatol 38(5):1251\u20131255","journal-title":"Clin Rheumatol"},{"issue":"3","key":"5616_CR38","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/jog.13237","volume":"43","author":"ZV Yilmaz","year":"2017","unstructured":"Yilmaz ZV, T\u00fcrkmen GG, Yilmaz E, Daglar K, Kibas A, Sanhal C, Y\u00fccel A, Uygur D (2017) Influence of Beh\u00e7et\u2019s disease on first and second trimester serum screening markers. J Obstet Gynaecol Res 43(3):511\u2013515","journal-title":"J Obstet Gynaecol Res"},{"issue":"11","key":"5616_CR39","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/pd.2116","volume":"28","author":"CA Spencer","year":"2008","unstructured":"Spencer CA, Allen VM, Flowerdew G, Dooley K, Dodds L (2008) Low levels of maternal serum PAPP-A in early pregnancy and the risk of averses outcomes. Prenat Diagn 28(11):1029\u20131036. https:\/\/doi.org\/10.1002\/pd.2116","journal-title":"Prenat Diagn"},{"key":"5616_CR40","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1073\/pnas.96.6.3149","volume":"96","author":"JB Lawrence","year":"1999","unstructured":"Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, Yates JR, Conover CA (1999) The insulin-like growth factor (IGF)-dependent binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci 96:3149\u20133153","journal-title":"Proc Natl Acad Sci"},{"key":"5616_CR41","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/j.1471-0528.2000.tb11618.x","volume":"107","author":"CYT Ong","year":"2000","unstructured":"Ong CYT, Liao AW, Spencer K, Munim S, Nicolaides KH (2000) First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. Br J Obstet Gynaecol 107:1265\u20131270","journal-title":"Br J Obstet Gynaecol"},{"key":"5616_CR42","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.ajog.2004.06.052","volume":"191","author":"L Dugoff","year":"2004","unstructured":"Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, Hankins G, Berkowitz RL, Merkatz I, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Vidaver J, D'Alton ME (2004) First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial). Am J Obstet Gynecol 191:1446\u20131451","journal-title":"Am J Obstet Gynecol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05616-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05616-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05616-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T16:12:49Z","timestamp":1623255169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05616-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,9]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["5616"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05616-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,9]]},"assertion":[{"value":"2 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}